EP4021381A1 - Oil substitute for cosmetic preparations - Google Patents
Oil substitute for cosmetic preparationsInfo
- Publication number
- EP4021381A1 EP4021381A1 EP20764041.8A EP20764041A EP4021381A1 EP 4021381 A1 EP4021381 A1 EP 4021381A1 EP 20764041 A EP20764041 A EP 20764041A EP 4021381 A1 EP4021381 A1 EP 4021381A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- inci
- preparation
- oil
- seed oil
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 80
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 22
- 239000001341 hydroxy propyl starch Substances 0.000 claims abstract description 22
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims abstract description 22
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 21
- 239000010452 phosphate Substances 0.000 claims abstract description 21
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims abstract description 12
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940098385 triisostearin Drugs 0.000 claims abstract description 12
- 229920002545 silicone oil Polymers 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 239000002480 mineral oil Substances 0.000 claims abstract description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 30
- 239000003921 oil Substances 0.000 claims description 22
- 235000019198 oils Nutrition 0.000 claims description 21
- -1 compounds caprylic / capric acid triglycerides Chemical class 0.000 claims description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 9
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 8
- 244000060011 Cocos nucifera Species 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229940071160 cocoate Drugs 0.000 claims description 7
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 229920000058 polyacrylate Polymers 0.000 claims description 6
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 5
- 244000020551 Helianthus annuus Species 0.000 claims description 5
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- 229940049294 glyceryl stearate se Drugs 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 4
- 229940045898 sodium stearoyl glutamate Drugs 0.000 claims description 4
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 239000001993 wax Substances 0.000 claims description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 229960002446 octanoic acid Drugs 0.000 claims description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 claims description 2
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- 229940031723 1,2-octanediol Drugs 0.000 claims description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- FVKRIDSRWFEQME-UHFFFAOYSA-N 3-methylbutyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCC(C)C FVKRIDSRWFEQME-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 240000005528 Arctium lappa Species 0.000 claims description 2
- 235000003130 Arctium lappa Nutrition 0.000 claims description 2
- 235000016108 Argania sideroxylon Nutrition 0.000 claims description 2
- 244000125300 Argania sideroxylon Species 0.000 claims description 2
- 235000005637 Brassica campestris Nutrition 0.000 claims description 2
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 claims description 2
- 235000008697 Cannabis sativa Nutrition 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000004341 Gossypium herbaceum Nutrition 0.000 claims description 2
- 240000002024 Gossypium herbaceum Species 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 2
- 240000007575 Macadamia integrifolia Species 0.000 claims description 2
- 241000208473 Macadamia ternifolia Species 0.000 claims description 2
- 235000017011 Mandorlo dulce Nutrition 0.000 claims description 2
- 244000076313 Mandorlo dulce Species 0.000 claims description 2
- 235000021360 Myristic acid Nutrition 0.000 claims description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 2
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 2
- 240000008916 Oenothera biennis Species 0.000 claims description 2
- 235000002725 Olea europaea Nutrition 0.000 claims description 2
- 240000007817 Olea europaea Species 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000014643 Orbignya martiana Nutrition 0.000 claims description 2
- 244000021150 Orbignya martiana Species 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 244000025272 Persea americana Species 0.000 claims description 2
- 235000011236 Persea americana var americana Nutrition 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 240000000528 Ricinus communis Species 0.000 claims description 2
- 235000004443 Ricinus communis Nutrition 0.000 claims description 2
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 235000010841 Silybum marianum Nutrition 0.000 claims description 2
- 244000272459 Silybum marianum Species 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 229940048300 coco-caprylate Drugs 0.000 claims description 2
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 claims description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 claims description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 2
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 125000004494 ethyl ester group Chemical group 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 229940045761 evening primrose extract Drugs 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 235000002532 grape seed extract Nutrition 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- 229940078565 isoamyl laurate Drugs 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- 239000007764 o/w emulsion Substances 0.000 claims description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 claims description 2
- 239000001944 prunus armeniaca kernel oil Substances 0.000 claims description 2
- 229940057910 shea butter Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- PJHKBYALYHRYSK-UHFFFAOYSA-N triheptanoin Chemical compound CCCCCCC(=O)OCC(OC(=O)CCCCCC)COC(=O)CCCCCC PJHKBYALYHRYSK-UHFFFAOYSA-N 0.000 claims description 2
- 229940078561 triheptanoin Drugs 0.000 claims description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229940039346 isoamyl cocoate Drugs 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 229920003012 Hydroxypropyl distarch phosphate Polymers 0.000 description 1
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 description 1
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001310 hydroxy propyl distarch phosphate Substances 0.000 description 1
- 235000013825 hydroxy propyl distarch phosphate Nutrition 0.000 description 1
- DVROLKBAWTYHHD-UHFFFAOYSA-N hydroxy propyl distarch phosphate Chemical compound OC1C(O)C(OC)OC(CO)C1OC(O)CCOC1C(OC2C(C(O)C(OC3C(C(OP(O)(=O)OC4C(C(O)C(OC)OC4CO)O)C(C)OC3CO)O)OC2COC2C(C(O)C(OC)C(CO)O2)O)O)OC(CO)C(OC)C1O DVROLKBAWTYHHD-UHFFFAOYSA-N 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/34—Free of silicones
Definitions
- the present invention relates to the use of a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations and their use in cosmetic preparations.
- hydroxypropyl starch phosphate INCI: Hydroxypropyl Starch Phosphate
- octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations and their use in cosmetic preparations.
- Skin care products usually creams, ointments or lotions, are mostly used to moisturize and re-oil the skin. Often, active ingredients are added to them that regenerate the skin and, for example, prevent and reduce its premature aging (e.g. the appearance of fine lines and wrinkles).
- cosmetics In addition to cleaning and caring for the skin, cosmetics also have an aesthetic function.
- Cosmetics thus fulfill a psychological and social function, as they increase the (visual) attractiveness of the user.
- This area includes, above all, “decorative” cosmetics, which change the appearance of the user with the help of dyes applied to the skin. But cleaning and care products also have a positive influence indirectly, since clean, healthy skin corresponds to people's ideal of beauty.
- a cosmetic preparation in particular an emulsion and here an O / W emulsion
- these preparations should ideally be “vegan”, that is, they should do without ingredients of animal origin.
- the aim was to develop a preparation whose ingredients are of plant origin, whereby plant origin also includes substances whose starting material comes from plants and which then go through one or more derivatization steps (e.g. hydrolysis, esterification).
- the objects are surprisingly achieved by using a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations.
- hydroxypropyl starch phosphate INCI: Hydroxypropyl Starch Phosphate
- octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations.
- a cosmetic preparation containing a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin, the preparation being free from mineral oils, silicone oils, polyacrylates and xanthan gum. It is advantageous according to the invention if the weight ratio of a) hydroxypropyl starch phosphate to b) total amount of esters of octyldodecanol or triisostearin is from 5: 1 to 1: 5 and preferably from 2: 1 to 1: 2 according to the invention.
- Hydroxypropyl starch phosphates such as those described in US Pat. No. 6,248,338 are particularly advantageous.
- the embodiments of the present invention which are advantageous according to the invention are characterized in that one or more esters of caprylic acid and / or capric acid are selected as further ingredients from the group of the compounds caprylic acid / capric acid triglycerides (INCI: caprylic / capric triglyceride), caprylyl caprylate / caprate (INCI: CaprylylCaprylate / Caprate), coconut Caprylate / Caprate (INCI: Coco Caprylate / Caprate), coconut Glyceride (INCI: Coco Glycerides), Ethylhexyl Cocoate (INCI: Ethyl Hexyl Cocoate), Decylcocoat (INCI: Decyl Cocoamylate), Isoam Cocoate), Dicaprylyl Carbonate (INCI: Dicaprylyl Carbonate), coconut Caprylate (INCI: Coco-Caprylate)
- the preparation contains the hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation.
- hydroxypropyl starch phosphate INCI: Hydroxypropyl Starch Phosphate
- the preparation contains the combination of hydroxypropyl starch phosphate and octyldodecanol, it is advantageous according to the invention if the preparation contains octyldodecanol in an amount of 0.1 to 3% by weight, based on the total weight of the preparation.
- the preparation contains the combination of hydroxypropyl starch phosphate and triisostearin, it is advantageous according to the invention if the preparation contains triisostearin in an amount of 0.1 to 3% by weight (and preferably up to 2% by weight), based on the total weight of the preparation.
- the preparation contains the combination of hydroxypropyl starch phosphate, octyldodecanol and triisostearin
- the preparation octyldodecanol in an amount of 0.1 to 2% by weight (preferably up to 1% by weight), based on the total weight of the preparation and triisostearin in an amount of 0.1 to 2% by weight (preferably up to 1.5% by weight), based on the total weight of the preparation.
- preparations according to the invention are advantageously characterized in that the preparation is in the form of an emulsion.
- the preparation is in the form of an oil-in-water emulsion (O / W emulsion).
- the particularly preferred embodiments according to the invention are characterized in that the preparation has one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate (INCI: glyceryl stearate citrate), sodium stearoyl glutamate (INCI: sodium stearoyl glutamate), glyceryl stearate SE (INCI: glyceryl Stearate SE), Sodium Cetearyl Sulfate (INCLSodium Cetearyl Sulfate), Stearic Acid (INCI: Palmitic Acid + Stearic Acid + Myristic Acid + Arachidic Acid + Oleic Acid), Glyceryl Stearate (INCI: Glyceryl Stearate), Polyglyceryl-3 Diisostearate (INC. 3 Diisostearate) ) contains.
- glyceryl stearate citrate ICI: glyceryl stearate citrate
- sodium stearoyl glutamate ICI: sodium stearoy
- the emulsifiers are used in a concentration of 0.1 to 5% by weight, based on the total weight of the preparation.
- inventions of the present invention which are advantageous according to the invention are further characterized in that the preparation is free from polyethylene glycol ethers and esters and is free from parabens, methylisothiazolinone, chloromethylisothiazolinone and DMDM hydantoin.
- preparation according to the invention should advantageously be free from animal components.
- the preparation contains waxes and / or fatty alcohols.
- waxes or fatty alcohols from the list of the following compounds are preferably used: cetearyl alcohol, cetyl alcohol, stearyl alcohol, Butyrospermum Parkii butter, cetyl palmitate, methyl palmitate, myristyl myristate, hydrogenated coco-glycerides, myristyl alcohol, behenyl alcohol, hydrogenated Castor Oil, Theobroma Cacao Seed Butter, Hydrogenated Rapeseed Oil, Caprylic / Capric / Myristic / Stearic Triglyceride, Hydrogenated Vegetable Oil, Carnauba Wax, Candelilla Wax, Sunflower Wax, Tristearin.
- the embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation contains additional vegetable oils selected from the group Persea Gratissima Oil, Orbignya Oleifera Seed Oil, Argania Spinosa Kernel Oil, Prunus Armeniaca Kernel Oil, Simmondsia Chinensis Seed Oil, Cocos Nucifera Oil, Silybum Marianum Seed Oil, Oenothera Biennis Oil, Olea Europaea Fruit Oil, Helianthus Annuus Seed Oil, Vitis Vinifera Seed Oil, Cannabis Sativa Seed Oil, Olus Oil, Vegetable Oil, Gossypium Herbaceum Seed Oil, Arctium Lappa Seed Oil, Macadamia Ternifolia Seed Oil, Macadamia Integrifolia Seed Oil, Zea Mays Germ Oil, Prunus Amygdalus Dulcis Oil, Ricinus Communis Seed Oil, Glycine Soja Oil, Helianthus Annuus Hybrid Oil,
- the preparation contains one or more lipophilic components selected from the group of the compounds dicaprylyl ether, decyl oleate, squalane, shea butter ethyl ester, triheptanoin, hexyl decyl sterate, isoamyl laurate.
- Advantageous embodiments of the present invention are also characterized in that the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl Contains 1, 3-propanediol, ethylhexylglycerin.
- Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosyl rutin, carnitine, carnosine, natural isoflavonoids, flavonoids , Creatine, creatinine, taurine, b-alanine, tocopherol, panthenol, magnolol, honokiol, glycerylglycose, hyaluronic acid and / or salts thereof and / or licochalcone A.
- the preparation has one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosyl rutin, carnitine, carnosine, natural isoflavonoids, flavonoids , Creatine, creat
- compositions according to the invention can also contain further cosmetic ingredients.
- the preparation contains fillers, in particular tapioca starch.
- the use concentration advantageous according to the invention for tapioca starch is 0.05 to 3.0% by weight, based on the total weight of the preparation.
- Tapioca starch has the advantage over other fillers such as zinc oxide that the preparation does not become too firm.
- the water phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol.
- customary cosmetic auxiliaries such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol.
- the effect according to the invention could be demonstrated by way of example with the following experiment: The preparations cream 10, cream 11 and cream 12 of the example formulations were produced and their whiteness was determined when they were distributed on the skin.
- test products are evaluated by trained subjects (panelists, approx. 10-15) using a highly standardized procedure.
- the products are applied to the inside of the forearm, distributed and rated directly. The higher the value, the more pronounced the whiteness of the product.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the use of a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and/or triisostearin as a substitute for mineral oils and silicone oils in cosmetic preparations and to their use in cosmetic preparations.
Description
Beiersdorf Aktiengesellschaft Hamburg Beiersdorf Aktiengesellschaft Hamburg
Beschreibung description
Ölersatz für kosmetische Zubereitunaen Oil substitute for cosmetic preparations
Die vorliegende Erfindung betrifft die Verwendung einer Mischung aus a) Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und b) Octyldodecanol und/oder Triisostearin als Ersatzstoff für Mineral- und Silikonöle in kosmetischen Zubereitungen und deren Einsatz in kosmetischen Zubereitungen. The present invention relates to the use of a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations and their use in cosmetic preparations.
Der Wunsch, schön und attraktiv auszusehen, ist von Natur aus im Menschen verwurzelt. Auch wenn das Schönheitsideal im Laufe der Zeit Wandlungen erfahren hat, so ist das Streben nach einem makellosen Äußeren, immer das Ziel der Menschen gewesen. Einen wesentlichen Anteil an einem schönen und attraktiven Äußeren hat dabei der Zustand und das Aussehen der Haut. The desire to look beautiful and attractive is inherently rooted in people. Even if the ideal of beauty has changed in the course of time, striving for a flawless appearance has always been the goal of people. The condition and appearance of the skin play a key role in a beautiful and attractive appearance.
Damit die Haut ihre biologischen Funktionen im vollen Umfang erfüllen kann, bedarf sie der regelmäßigen Reinigung und Pflege. Hautpflegeprodukte, in der Regel Cremes, Salben oder Lotionen, dienen meist der Befeuchtung und Rückfettung der Haut. Häufig sind ihnen Wirkstoffe zugesetzt, welche die Haut regenerieren und beispielsweise ihre vorzeitige Alterung (z.B. das Entstehen von Fältchen, Falten) verhindern und vermindern sollen. In order for the skin to be able to fully fulfill its biological functions, it needs regular cleaning and care. Skin care products, usually creams, ointments or lotions, are mostly used to moisturize and re-oil the skin. Often, active ingredients are added to them that regenerate the skin and, for example, prevent and reduce its premature aging (e.g. the appearance of fine lines and wrinkles).
Neben der Reinigung und Pflege der Haut haben Kosmetika auch eine ästhetische Aufgabe.In addition to cleaning and caring for the skin, cosmetics also have an aesthetic function.
Sie sollen das äußere Erscheinungsbild des Anwenders entsprechend den jeweiligen kulturellen Vorstellungen „verbessern“. Kosmetika erfüllen damit eine psychologisch-soziale Funktion, da sie die (optische) Attraktivität der Anwender erhöhen. In diesen Bereich fällt vor allen Dingen die „dekorative“ Kosmetik, die mit Hilfe von auf die Haut aufgetragenen Farbstoffen das Erscheinungsbild der Anwender verändert. Indirekt haben aber auch Reinigungs- und Pflegeprodukte einen positiven Einfluss, da eine saubere, gesunde Haut dem Schönheitsideal der Menschen entspricht. They should "improve" the external appearance of the user according to the respective cultural ideas. Cosmetics thus fulfill a psychological and social function, as they increase the (visual) attractiveness of the user. This area includes, above all, “decorative” cosmetics, which change the appearance of the user with the help of dyes applied to the skin. But cleaning and care products also have a positive influence indirectly, since clean, healthy skin corresponds to people's ideal of beauty.
In jüngerer Zeit gibt es einen verstärkten Trend hin zu „natürlichen“ Kosmetika, deren Inhaltsstoffe möglichst nicht mehr aus Erdölprodukten stammen oder chemisch synthetisiert sein sollen. Dieser Trend überlappt sich heutzutage mit dem Trend hin zu „veganen“ Produkten. Dabei stellt die Suche nach alternativen Inhaltsstoffen, welche diese Kriterien erfüllen, die
Produktentwickler vor besondere Herausforderungen. Denn der Austausch der bekannten Inhaltstoffe wie Mineralöle, Silikonöle, Polyacrylate wird praktisch immer mit Nachteilen im Hinblick auf die Anwendung der Produkte erkauft. Die Zubereitungen werden sensorisch unattraktiv, was sich beispielsweise beim Verteilen der Zubereitung auf der Haut und dem mangelnden Einzugsvermögen unangenehm bemerkbar macht. So führt unter anderem der Austausch von Mineralölen, Silikonölen und Polyacrylaten wie Carbomeren, Acrylates/C 10-30 Alkylacrylate Crosspolymer zu einem verstärkten „Weißein“ beim Verreiben der Zubereitung auf der Haut. Dieses „Weißein“ tritt insbesondere bei Zubereitungen auf, bei denen das häufig verwendete Xanthangummi (INCI Xanthan Gum) anstelle der Polyacrylate eingesetzt wird. Außerdem tritt bei Verwendung von Xanthangummi eine fadenziehende Struktur in Erscheinung, das heißt die Formel bildet Fäden wenn sie zwischen den Fingern auseinandergezogen wird. Recently there has been an increased trend towards “natural” cosmetics, the ingredients of which should no longer come from petroleum products or should be chemically synthesized. This trend now overlaps with the trend towards “vegan” products. The search for alternative ingredients that meet these criteria represents the Product developers face special challenges. Because the exchange of the known ingredients such as mineral oils, silicone oils, polyacrylates is practically always paid for with disadvantages with regard to the application of the products. The preparations become unattractive from a sensory point of view, which becomes unpleasantly noticeable, for example, when the preparation is distributed on the skin and the lack of absorption capacity. For example, the replacement of mineral oils, silicone oils and polyacrylates such as carbomers, acrylates / C 10-30 alkyl acrylate cross-polymer leads to increased "whiteness" when the preparation is rubbed on the skin. This "whiteness" occurs in particular in preparations in which the frequently used xanthan gum (INCI Xanthan Gum) is used instead of polyacrylates. In addition, when xanthan gum is used, a stringy structure appears, i.e. the formula forms strings when it is pulled apart between the fingers.
Es war daher die Aufgabe der vorliegenden Erfindung, einen Ersatz für Mineralöle und Silikonöle in kosmetischen Zubereitungen zu finden, welcher die gleichen sensorischen Eigenschaften (insbesondere im Hinblick auf das Weißein, die Verteilbarkeit auf der Haut und das Einzugsvermögen) hat, wie die Mineral-und Silikonöle. It was therefore the object of the present invention to find a replacement for mineral oils and silicone oils in cosmetic preparations which has the same sensory properties (in particular with regard to whiteness, spreadability on the skin and absorbability) as mineral and Silicone oils.
Ferner war es die Aufgabe der vorliegenden Erfindung eine kosmetische Zubereitung (insbesondere eine Emulsion und hier eine O/W-Emulsion) zu entwickeln, die frei ist von Mineralöle, Silikonölen und Polyacrylaten, welche die gleichen sensorischen Eigenschaften aufweist wie herkömmliche Kosmetika, welche diese Inhaltsstoffe enthalten. Diese Zubereitungen sollten idealerweise „vegan“ sein, das heißt ohne Inhaltsstoffe tierischen Ursprunges auskommen. Darüber hinaus wurde angestrebt, eine Zubereitung zu entwickeln, deren Inhaltsstoffe pflanzlichen Ursprungs sind, wobei unter pflanzlichen Ursprung auch solche Stoffe zu verstehen sind, deren Ausgangsstoff aus Pflanzen stammt und die anschließend einen oder mehrere Derivatisierungsschritte (z.B. Hydrolyse, Veresterung) durchlaufen. Furthermore, it was the object of the present invention to develop a cosmetic preparation (in particular an emulsion and here an O / W emulsion) which is free from mineral oils, silicone oils and polyacrylates, which has the same sensory properties as conventional cosmetics which contain these ingredients contain. These preparations should ideally be "vegan", that is, they should do without ingredients of animal origin. In addition, the aim was to develop a preparation whose ingredients are of plant origin, whereby plant origin also includes substances whose starting material comes from plants and which then go through one or more derivatization steps (e.g. hydrolysis, esterification).
Überraschend gelöst werden die Aufgaben durch die Verwendung einer Mischung aus a) Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und b) Octyldodecanol und/oder Triisostearin als Ersatzstoff für Mineral- und Silikonöle in kosmetischen Zubereitungen. The objects are surprisingly achieved by using a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations.
Überraschend werden die Aufgaben ferner gelöst durch eine kosmetische Zubereitung enthaltend eine Mischung aus a) Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und b) Octyldodecanol und/oder Triisostearin, wobei die Zubereitung frei ist von, Mineralölen, Silikonölen, Polyacrylaten und Xanthangummi.
Dabei ist es erfindungsgemäß vorteilhaft, wenn das Gewichtsverhältnis von a) Hydroxypropylstärkephosphat zur b) Gesamtmenge an Estern der Octyldodecanol beziehungsweise Triisostearin von 5:1 bis 1 :5 beträgt und erfindungsgemäß bevorzugt von 2:1 bis 1 :2 beträgt. Surprisingly, the objects are also achieved by a cosmetic preparation containing a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin, the preparation being free from mineral oils, silicone oils, polyacrylates and xanthan gum. It is advantageous according to the invention if the weight ratio of a) hydroxypropyl starch phosphate to b) total amount of esters of octyldodecanol or triisostearin is from 5: 1 to 1: 5 and preferably from 2: 1 to 1: 2 according to the invention.
Im Rahmen der vorliegenden Offenbarung bezieht sich die Formulierung „erfindungsgemäß“ immer auf die erfindungsgemäßen Zubereitungen und Verwendungen, für den Fall, dass nichts anderes angegeben ist. In the context of the present disclosure, the phrase “according to the invention” always relates to the preparations and uses according to the invention, in the event that nothing else is stated.
Insbesondere vorteilhaft sind solche Hydroxypropylstärkephosphate, wie sie in der US 6248338 beschrieben werden. Ganz besonders bevorzugt ist dabei der Einsatz eines Hydroxypropyldistärkephosphates, wie es als Produkt Structure® XL der Firma Nouryon verkauft wird. Hydroxypropyl starch phosphates such as those described in US Pat. No. 6,248,338 are particularly advantageous. The use of a hydroxypropyl distarch phosphate, such as that sold as the Structure® XL product from Nouryon, is very particularly preferred.
Die erfindungsgemäß vorteilhaften Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass die Zubereitung als weiteren Inhaltsstoffe einen oder mehrere Ester der Caprylsäure und/oder Caprinsäure gewählt werden aus der Gruppe der Verbindungen Caprylsäure-/Caprinsäuretriglyceride (INCI : Caprylic/Capric Triglyceride), Caprylylcaprylat/Caprat (INCI: CaprylylCaprylate/Caprate), Kokoscaprylat/Caprat (INCI: Coco Caprylate/Caprate), Kokosglyceride (INCI: Coco Glycerides), Ethylhexylcocoat (INCI: Ethyl Hexyl Cocoate), Decylcocoat (INCI: Decyl Cocoate), Isoamylcocoat (INCI: Isoamyl Cocoate), Dicaprylyl Carbonat (INCI: Dicaprylyl Carbonate), Kokoscaprylat (INCI: Coco-Caprylate)The embodiments of the present invention which are advantageous according to the invention are characterized in that one or more esters of caprylic acid and / or capric acid are selected as further ingredients from the group of the compounds caprylic acid / capric acid triglycerides (INCI: caprylic / capric triglyceride), caprylyl caprylate / caprate (INCI: CaprylylCaprylate / Caprate), Coconut Caprylate / Caprate (INCI: Coco Caprylate / Caprate), Coconut Glyceride (INCI: Coco Glycerides), Ethylhexyl Cocoate (INCI: Ethyl Hexyl Cocoate), Decylcocoat (INCI: Decyl Cocoamylate), Isoam Cocoate), Dicaprylyl Carbonate (INCI: Dicaprylyl Carbonate), Coconut Caprylate (INCI: Coco-Caprylate)
Für die erfindungsgemäße Zubereitung ist es erfindungsgemäß von Vorteil, wenn die Zubereitung das Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) in einer Konzentration von 0,2 bis 5 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. For the preparation according to the invention it is advantageous according to the invention if the preparation contains the hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation.
Die erfindungsgemäße Zubereitung kann vorteilhaft in drei unterschiedlichen Formen vorliegen:The preparation according to the invention can advantageously be in three different forms:
Enthält die Zubereitung die Kombination aus Hydroxypropylstärkephosphat und Octyldodecanol, so ist es erfindungsgemäß vorteilhaft, wenn die Zubereitung Octyldodecanol in einer Menge von 0,1 bis 3 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung enthält. If the preparation contains the combination of hydroxypropyl starch phosphate and octyldodecanol, it is advantageous according to the invention if the preparation contains octyldodecanol in an amount of 0.1 to 3% by weight, based on the total weight of the preparation.
Enthält die Zubereitung die Kombination aus Hydroxypropylstärkephosphat und Triisostearin, so ist es erfindungsgemäß vorteilhaft, wenn die Zubereitung Triisostearin in einer Menge von 0,1 bis 3 Gewichts-% (und bevorzugt bis 2 Gewichts-%), bezogen auf das Gesamtgewicht der Zubereitung enthält.
Enthält die Zubereitung die Kombination aus Hydroxypropylstärkephosphat, Octyldodecanol und Triisostearin, so ist erfindungsgemäß vorteilhaft, wenn die Zubereitung Octyldodecanol in einer Menge von 0,1 bis 2 Gewichts-% (bevorzugt bis 1 Gewichts-%), bezogen auf das Gesamtgewicht der Zubereitung und Triisostearin in einer Menge von 0,1 bis 2 Gewichts-% (bevorzugt bis 1 ,5 Gewichts-%), bezogen auf das Gesamtgewicht der Zubereitung enthält.If the preparation contains the combination of hydroxypropyl starch phosphate and triisostearin, it is advantageous according to the invention if the preparation contains triisostearin in an amount of 0.1 to 3% by weight (and preferably up to 2% by weight), based on the total weight of the preparation. If the preparation contains the combination of hydroxypropyl starch phosphate, octyldodecanol and triisostearin, it is advantageous according to the invention if the preparation octyldodecanol in an amount of 0.1 to 2% by weight (preferably up to 1% by weight), based on the total weight of the preparation and triisostearin in an amount of 0.1 to 2% by weight (preferably up to 1.5% by weight), based on the total weight of the preparation.
Darüber hinaus sind die erfindungsgemäßen Zubereitungen vorteilhaft dadurch gekennzeichnet, dass die Zubereitung in Form einer Emulsion vorliegt. In addition, the preparations according to the invention are advantageously characterized in that the preparation is in the form of an emulsion.
In einem solchen Falle ist es erfindungsgemäß bevorzugt, wenn die Zubereitung in Form einer Öl-in-Wasser Emulsion (O/W-Emulsion) vorliegt. In such a case it is preferred according to the invention if the preparation is in the form of an oil-in-water emulsion (O / W emulsion).
In einem solchen Falle sind die erfindungsgemäß besonders bevorzugten Ausführungsformen dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere Emulgatoren gewählt aus der Gruppe der Verbindungen Glycerylstearatcitrat (INCI : Glyceryl Stearat Citrate), Natriumstearoylglutamat (INCI: Sodium Stearoyl Glutamate), Glycerylstearat SE (INCI: Glyceryl Stearate SE), Natriumcetearylsulfat (INCLSodium Cetearyl Sulfate), Stearinsäure (INCI: Palmitic Acid + Stearic Acid + Myristic Acid + Arachidic Acid + Oleic Acid) , Glyceryl Stearate (INCI: Glyceryl Stearate), Polyglyceryl-3 Diisostearat (INCI Polyglyceryl-3 Diisostearate ) enthält. In such a case, the particularly preferred embodiments according to the invention are characterized in that the preparation has one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate (INCI: glyceryl stearate citrate), sodium stearoyl glutamate (INCI: sodium stearoyl glutamate), glyceryl stearate SE (INCI: glyceryl Stearate SE), Sodium Cetearyl Sulfate (INCLSodium Cetearyl Sulfate), Stearic Acid (INCI: Palmitic Acid + Stearic Acid + Myristic Acid + Arachidic Acid + Oleic Acid), Glyceryl Stearate (INCI: Glyceryl Stearate), Polyglyceryl-3 Diisostearate (INC. 3 Diisostearate) ) contains.
Es ist dabei erfindungsgemäß vorteilhaft, wenn die Emulgatoren in einer Einsatzkonzentration von 0,1 bis 5 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt werden. It is advantageous according to the invention if the emulsifiers are used in a concentration of 0.1 to 5% by weight, based on the total weight of the preparation.
Die erfindungsgemäß vorteilhaften Ausführungsformen der vorliegenden Erfindung sind ferner dadurch gekennzeichnet, dass die Zubereitung frei ist Polyethylenglycolethern und-estern, sowie frei ist von Parabenen, Methylisothiazolinon, Chlormethylisothiazolinon und DMDM- Hydantoin. The embodiments of the present invention which are advantageous according to the invention are further characterized in that the preparation is free from polyethylene glycol ethers and esters and is free from parabens, methylisothiazolinone, chloromethylisothiazolinone and DMDM hydantoin.
Darüber hinaus sollte die erfindungsgemäße Zubereitung vorteilhafter Weise frei sein von tierischen Bestandteilen. In addition, the preparation according to the invention should advantageously be free from animal components.
Es ist vorteilhaft im Sinne der vorliegenden Erfindung, wenn die Zubereitung Wachse und/oder Fettalkohole enthält. Dabei werden erfindungsgemäß bevorzugt Wachse bzw. Fettalkohole aus der Liste der folgenden Verbindungen eingesetzt: Cetearyl Alkohol, Cetyl Alkohol , Stearyl Alkohol, Butyrospermum Parkii Butter, Cetyl Palmitat, Methyl Palmitate, Myristyl Myristate, Hydrogenated Coco-Glycerides, Myristyl Alkohol, Behenyl Alkohol, Hydrogenated Castor Oil, Theobroma Cacao Seed Butter, Hydrogenated Rapeseed Oil, Caprylic/Capric/ Myristic/Stearic Triglycerid, Hydrogenated Vegetable Oil, Carnaubawachs, Candelillawachs, Sonnenblumenwachs, Tristearin.
Außerdem sind die erfindungsgemäß vorteilhaften Ausführungsformen der vorliegenden Erfindung dadurch gekennzeichnet, dass die Zubereitung zusätzliche pflanzliche Öle gewählt aus der Gruppe Persea Gratissima Oil, Orbignya Oleifera Seed Oil, Argania Spinosa Kernel Oil, Prunus Armeniaca Kernel Oil, Simmondsia Chinensis Seed Oil, Cocos Nucifera Oil, Silybum Marianum Seed Oil, Oenothera Biennis Oil, Olea Europaea Fruit Oil, Helianthus Annuus Seed Oil, Vitis Vinifera Seed Oil, Cannabis Sativa Seed Oil, Olus Oil, Vegetable Oil, Gossypium Herbaceum Seed Oil, Arctium Lappa Seed Oil, Macadamia Ternifolia Seed Oil, Macadamia Integrifolia Seed Oil, Zea Mays Germ Oil, Prunus Amygdalus Dulcis Oil, Ricinus Communis Seed Oil, Glycine Soja Oil, Helianthus Annuus Hybrid Oil, Sesamum Indicum Seed Oil, Brassica Campestris Seed Oil enthält. It is advantageous for the purposes of the present invention if the preparation contains waxes and / or fatty alcohols. According to the invention, waxes or fatty alcohols from the list of the following compounds are preferably used: cetearyl alcohol, cetyl alcohol, stearyl alcohol, Butyrospermum Parkii butter, cetyl palmitate, methyl palmitate, myristyl myristate, hydrogenated coco-glycerides, myristyl alcohol, behenyl alcohol, hydrogenated Castor Oil, Theobroma Cacao Seed Butter, Hydrogenated Rapeseed Oil, Caprylic / Capric / Myristic / Stearic Triglyceride, Hydrogenated Vegetable Oil, Carnauba Wax, Candelilla Wax, Sunflower Wax, Tristearin. In addition, the embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation contains additional vegetable oils selected from the group Persea Gratissima Oil, Orbignya Oleifera Seed Oil, Argania Spinosa Kernel Oil, Prunus Armeniaca Kernel Oil, Simmondsia Chinensis Seed Oil, Cocos Nucifera Oil, Silybum Marianum Seed Oil, Oenothera Biennis Oil, Olea Europaea Fruit Oil, Helianthus Annuus Seed Oil, Vitis Vinifera Seed Oil, Cannabis Sativa Seed Oil, Olus Oil, Vegetable Oil, Gossypium Herbaceum Seed Oil, Arctium Lappa Seed Oil, Macadamia Ternifolia Seed Oil, Macadamia Integrifolia Seed Oil, Zea Mays Germ Oil, Prunus Amygdalus Dulcis Oil, Ricinus Communis Seed Oil, Glycine Soja Oil, Helianthus Annuus Hybrid Oil, Sesamum Indicum Seed Oil, Brassica Campestris Seed Oil.
Darüber hinaus wurde festgestellt, dass es erfindungsgemäß von besonderem Vorteil ist, wenn die Zubereitung ein oder mehrere lipophile Komponenten gewählt aus der Gruppe der Verbindungen Dicaprylyl Ether, Decyl Oleate, Squalane, Shea Butter Ethyl Ester, Triheptanoin, Hexyldecylsterat, Isoamyllaurat, enthält. In addition, it was found that it is particularly advantageous according to the invention if the preparation contains one or more lipophilic components selected from the group of the compounds dicaprylyl ether, decyl oleate, squalane, shea butter ethyl ester, triheptanoin, hexyl decyl sterate, isoamyl laurate.
Vorteilhafte Ausführungsformen der vorliegenden Erfindung sind auch dadurch gekennzeichnet, dass die Zubereitung ein oder mehrere Alkandiole aus der Gruppe der Verbindungen 1 ,2- Pentandiol, 1 ,2-Hexandiol, 1 ,2-Octandiol, 1 ,2-Decandiol, 2-Methyl-1 ,3-propandiol, Ethylhexylglycerin enthält. Advantageous embodiments of the present invention are also characterized in that the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl Contains 1, 3-propanediol, ethylhexylglycerin.
Erfindungsgemäß vorteilhafte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass die Zubereitung eine oder mehrere Verbindungen gewählt aus der Gruppe der Verbindungen alpha-Liponsäure, Folsäure, Phytoen, D-Biotin, Coenzym Q10, alpha-Glucosylrutin, Carnitin, Carnosin, natürliche Isoflavonoide, Flavonoide, Kreatin, Kreatinin, Taurin, b-Alanin, Tocopherol , Panthenol, Magnolol, Honokiol, Glycerylglycose, Hyaluronsäure und/oder deren Salze und/oder Licochalcon A enthält. Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosyl rutin, carnitine, carnosine, natural isoflavonoids, flavonoids , Creatine, creatinine, taurine, b-alanine, tocopherol, panthenol, magnolol, honokiol, glycerylglycose, hyaluronic acid and / or salts thereof and / or licochalcone A.
Die erfindungsgemäßen Zubereitungen können darüber hinaus weitere kosmetische Inhaltsstoffe enthalten. The preparations according to the invention can also contain further cosmetic ingredients.
So ist es erfindungsgemäß von Vorteil, wenn die Zubereitung Füllstoffe, insbesondere Tapiokastärke enthält. Die erfindungsgemäß vorteilhafte Einsatzkonzentration für Tapiokastärke beträgt dabei 0,05 bis 3,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung. Tapiokastärke hat dabei gegenüber anderen Füllstoffen wie beispielsweise Zinkoxid den Vorteil, dass die Zubereitung nicht zu fest wird. It is therefore advantageous according to the invention if the preparation contains fillers, in particular tapioca starch. The use concentration advantageous according to the invention for tapioca starch is 0.05 to 3.0% by weight, based on the total weight of the preparation. Tapioca starch has the advantage over other fillers such as zinc oxide that the preparation does not become too firm.
Die Wasserphase der erfindungsgemäßen Zubereitungen kann vorteilhaft übliche kosmetische Hilfsstoffe enthalten, wie beispielsweise Alkohole, insbesondere solche niedriger C-Zahl, vorzugsweise Ethanol.
Beispiele The water phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol. Examples
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzu schränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders an gegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zube- reitungen bezogen. The following examples are intended to illustrate the present invention without restricting it. Unless otherwise stated, all quantities, proportions and percentages are based on the weight and the total amount or the total weight of the preparations.
Beispielrezepturen (Creme 1-10: erfindungsgemäß, Creme 11-12: nicht erfindungsgemäß)
Example formulations (cream 1-10: according to the invention, cream 11-12: not according to the invention)
Vergleichsversuch Comparative experiment
Mit dem folgenden Versuch konnte der erfindungsgemäße Effekt beispielhaft belegt werden: Es wurden die Zubereitungen Creme 10, Creme 11 und Creme 12 der Beispielrezepturen hergestellt und ihr Weissein beim Verteilen auf der Haut bestimmt. The effect according to the invention could be demonstrated by way of example with the following experiment: The preparations cream 10, cream 11 and cream 12 of the example formulations were produced and their whiteness was determined when they were distributed on the skin.
Bewertuna des „Weißeins“ im Sensorik Panel Evaluation of the "whiteness" in the sensor panel
Sensorische Evaluierung von Leave-on Produkten. Sensory evaluation of leave-on products.
Die Testprodukte werden von trainierten Probanden (Panelisten, ca. 10-15) mittels einer hochstandardisierten Vorgehensweise bewertet. The test products are evaluated by trained subjects (panelists, approx. 10-15) using a highly standardized procedure.
Die Produkte werden dazu auf den Innenseiten des Unterarms appliziert, verteilt und direkt bewertet. Je höher der Wert, desto stärker ausgeprägt ist das Weißein des Produktes. The products are applied to the inside of the forearm, distributed and rated directly. The higher the value, the more pronounced the whiteness of the product.
In der Tabelle sind dargestellt die Werte für das Weißein nach 20 definiert ausgeführten Kreisen. Ergebnis (n=11)
The table shows the whiteness values according to 20 defined circles. Result (n = 11)
Claims
1. Verwendung einer Mischung aus a) Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und b) Octyldodecanol und/oder Triisostearin als Ersatzstoff für Mineral- und Silikonöle in kosmetischen Zubereitungen. 1. Use of a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin as a substitute for mineral and silicone oils in cosmetic preparations.
2. Kosmetische Zubereitung enthaltend eine Mischung aus a) Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) und b) Octyldodecanol und/oder Triisostearin, wobei die Zubereitung frei ist von, Mineralölen, Silikonölen, Polyacrylaten und Xanthangummi. 2. Cosmetic preparation containing a mixture of a) hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) and b) octyldodecanol and / or triisostearin, the preparation being free from mineral oils, silicone oils, polyacrylates and xanthan gum.
3. Verwendung nach Anspruch 1 oder Zubereitung nach Anspruch 2, dadurch gekennzeichnet, dass das Gewichtsverhältnis von a) Hydroxypropylstärekphosphat zur b) Gesamtmenge an Octyldodecanol beziehungsweise Triisostearin von 5:1 bis 1 :5 beträgt. 3. Use according to claim 1 or preparation according to claim 2, characterized in that the weight ratio of a) hydroxypropyl starch phosphate to b) total amount of octyldodecanol or triisostearin is from 5: 1 to 1: 5.
4. Verwendung oder Zubereitung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere Ester der Caprylsäure und/oder Caprinsäure enthält, die gewählt werden aus der Gruppe der Verbindungen Caprylsäure-/Caprinsäuretriglyceride (INCI: Caprylic/Capric Triglyceride), Caprylylcaprylat/Caprat (INCI: CaprylylCaprylate/Caprate), Kokoscaprylat/Caprat (INCI: Coco Caprylate/Caprate), Kokosglyceride (INCI: Coco Glycerides), Ethylhexylcocoat (INCI: Ethyl Hexyl Cocoate), Decylcocoat (INCI: Decyl Cocoate), Isoamylcocoat (INCI: Isoamyl Cocoate), Dicaprylyl Carbonat (INCI: Dicaprylyl Carbonate), Kokoscaprylat (INCI: Coco-Caprylate) 4. Use or preparation according to one of the preceding claims, characterized in that the preparation contains one or more esters of caprylic acid and / or capric acid, which are selected from the group of compounds caprylic / capric acid triglycerides (INCI: Caprylic / Capric Triglyceride), Caprylylcaprylate / Caprate (INCI: CaprylylCaprylate / Caprate), Coconut Caprylate / Caprate (INCI: Coco Caprylate / Caprate), Coconut Glyceride (INCI: Coco Glycerides), Ethylhexyl Cocoat (INCI: Ethyl Hexyl Cocoate), Decyl Cocoate (INCI: Coco Hexyl Cocoate), Decyl Cocoate (INCI: INCI: Isoamyl Cocoate), Dicaprylyl Carbonate (INCI: Dicaprylyl Carbonate), Coconut Caprylate (INCI: Coco-Caprylate)
5. Zubereitung nach einem der Ansprüche 2 bis 4, dadurch gekennzeichnet, dass die Zubereitung das Hydroxypropylstärkephosphat (INCI: Hydroxypropyl Starch Phosphate) in einer Konzentration von 0,2 bis 5 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. 5. Preparation according to one of claims 2 to 4, characterized in that the preparation contains the hydroxypropyl starch phosphate (INCI: Hydroxypropyl Starch Phosphate) in a concentration of 0.2 to 5% by weight, based on the total weight of the preparation.
6. Zubereitung nach einem der Ansprüche 2 bis 5, dadurch gekennzeichnet, dass die Zubereitung in Form einer Emulsion vorliegt. 6. Preparation according to one of claims 2 to 5, characterized in that the preparation is in the form of an emulsion.
7. Zubereitung nach einem der Ansprüche 2 bis 6, dadurch gekennzeichnet, dass die Zubereitung in Form einer Öl-in-Wasser Emulsion (O/W-Emulsion) vorliegt. 7. Preparation according to one of claims 2 to 6, characterized in that the preparation is in the form of an oil-in-water emulsion (O / W emulsion).
8. Zubereitung nach einem der Ansprüche 2 bis 7, dadurch gekennzeichnet, dass die Zubereitung frei ist Polyethylenglycolethern und-estern, sowie frei ist von Parabenen, Methylisothiazolinon, Chlormethylisothiazolinon und DMDM-Hydantoin. 8. Preparation according to one of claims 2 to 7, characterized in that the preparation is free of polyethylene glycol ethers and esters, and is free of parabens, methylisothiazolinone, chloromethylisothiazolinone and DMDM hydantoin.
9. Zubereitung nach einem der Ansprüche 2 bis 8, dadurch gekennzeichnet, dass die Zubereitung Wachse und/oder Fettalkohole enthält.
9. Preparation according to one of claims 2 to 8, characterized in that the preparation contains waxes and / or fatty alcohols.
10. Zubereitung nach einem der Ansprüche 2 bis 9, dadurch gekennzeichnet, dass die Zubereitung zusätzliche pflanzliche Öle gewählt aus der Gruppe Persea Gratissima Oil, Orbignya Oleifera Seed Oil, Argania Spinosa Kernel Oil, Prunus Armeniaca Kernel Oil, Simmondsia Chinensis Seed Oil, Cocos Nucifera Oil, Silybum Marianum Seed Oil, Oenothera Biennis Oil, Olea Europaea Fruit Oil, Helianthus Annuus Seed Oil, Vitis Vinifera Seed Oil, Cannabis Sativa Seed Oil, Olus Oil, , Vegetable Oil, Gossypium Herbaceum Seed Oil, Arctium Lappa Seed Oil, Macadamia Ternifolia Seed Oil, Macadamia Integrifolia Seed Oil, Zea Mays Germ Oil, Prunus Amygdalus Dulcis Oil, Ricinus Communis Seed Oil, Glycine Soja Oil, Helianthus Annuus Hybrid Oil, Sesamum Indicum Seed Oil, Brassica Campestris Seed Oil enthält. 10. Preparation according to one of claims 2 to 9, characterized in that the preparation includes additional vegetable oils selected from the group Persea Gratissima Oil, Orbignya Oleifera Seed Oil, Argania Spinosa Kernel Oil, Prunus Armeniaca Kernel Oil, Simmondsia Chinensis Seed Oil, Cocos Nucifera Oil, Silybum Marianum Seed Oil, Oenothera Biennis Oil, Olea Europaea Fruit Oil, Helianthus Annuus Seed Oil, Vitis Vinifera Seed Oil, Cannabis Sativa Seed Oil, Olus Oil,, Vegetable Oil, Gossypium Herbaceum Seed Oil, Arctium Lappa Seed Oil, Macadamia Ternifolia Seed Oil, Macadamia Integrifolia Seed Oil, Zea Mays Germ Oil, Prunus Amygdalus Dulcis Oil, Ricinus Communis Seed Oil, Glycine Soja Oil, Helianthus Annuus Hybrid Oil, Sesamum Indicum Seed Oil, Brassica Campestris Seed Oil.
11 . Zubereitung nach einem der Ansprüche 2 bis 10, dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere Emulgatoren gewählt aus der Gruppe der Verbindungen Glycerylstearatcitrat (INCI: Glyceryl Stearat Citrate), Natriumstearoylglutamat (INCI: Sodium Stearoyl Glutamate), Glycerylstearat SE (INCI: Glyceryl Stearate SE), Natriumcetearylsulfat (INCkSodium Cetearyl Sulfate), Stearinsäure (INCI: Palmitic Acid + Stearic Acid + Myristic Acid + Arachidic Acid + Oleic Acid) , Glyceryl Stearate (INCI: Glyceryl Stearate), Polyglyceryl-3 Diisostearat (INCI Polyglyceryl-3 Diisostearate) enthält. 11. Preparation according to one of claims 2 to 10, characterized in that the preparation has one or more emulsifiers selected from the group of the compounds glyceryl stearate citrate (INCI: glyceryl stearate citrate), sodium stearoyl glutamate (INCI: sodium stearoyl glutamate), glyceryl stearate SE (INCI: glyceryl stearate SE), sodium cetearyl sulfate (INCkSodium Cetearyl Sulfate), stearic acid (INCI: Palmitic Acid + Stearic Acid + Myristic Acid + Arachidic Acid + Oleic Acid), Glyceryl Stearate (INCI: Glyceryl Stearate), Polyglyceryl-3 Diisostearate (INCI) contains.
12. Zubereitung nach Anspruch 11 , dadurch gekennzeichnet, dass die Emulgatoren in einer Einsatzkonzentration von 0,1 bis 5 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt werden. 12. Preparation according to claim 11, characterized in that the emulsifiers are used in a concentration of 0.1 to 5% by weight, based on the total weight of the preparation.
13. Zubereitung nach einem der Ansprüche 2 bis 12, dadurch gekennzeichnet, dass die Zubereitung frei ist von tierischen Bestandteilen. 13. Preparation according to one of claims 2 to 12, characterized in that the preparation is free from animal components.
14. Zubereitung nach einem der Ansprüche 2 bis 13, dadurch gekennzeichnet, dass die Zubereitung ein oder mehrere lipophile Komponenten gewählt aus der Gruppe der Verbindungen Dicaprylyl Ether, Decyl Oleate, Squalane, Shea Butter Ethyl Ester, Triheptanoin, Hexyldecylsterat, Isoamyllaurat, enthält. 14. Preparation according to one of claims 2 to 13, characterized in that the preparation contains one or more lipophilic components selected from the group of compounds dicaprylyl ether, decyl oleate, squalane, shea butter ethyl ester, triheptanoin, hexyl decyl sterate, isoamyl laurate.
15. Zubereitung nach einem der Ansprüche 2 bis 13, dadurch gekennzeichnet, dass die Zubereitung ein oder mehrere Alkandiole aus der Gruppe der Verbindungen 1 ,2- Pentandiol, 1 ,2-Hexandiol, 1 ,2-Octandiol, 1 ,2-Decandiol, 2-Methyl-1 ,3-propandiol, Ethylhexylglycerin enthält.
15. Preparation according to one of claims 2 to 13, characterized in that the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, Contains 2-methyl-1,3-propanediol, ethylhexylglycerin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102019212792.4A DE102019212792A1 (en) | 2019-08-27 | 2019-08-27 | Oil substitutes for cosmetic preparations |
| PCT/EP2020/073488 WO2021037713A1 (en) | 2019-08-27 | 2020-08-21 | Oil substitute for cosmetic preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4021381A1 true EP4021381A1 (en) | 2022-07-06 |
Family
ID=72266273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20764041.8A Pending EP4021381A1 (en) | 2019-08-27 | 2020-08-21 | Oil substitute for cosmetic preparations |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4021381A1 (en) |
| DE (1) | DE102019212792A1 (en) |
| WO (1) | WO2021037713A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19627498A1 (en) | 1996-07-08 | 1998-01-15 | Nat Starch Chem Invest | Starchy cleaning and care products |
| WO2002000733A1 (en) * | 2000-06-26 | 2002-01-03 | National Starch And Chemical Investment Holding Corporation | Polysaccharide and dimethicone copolyol as emulsifier for cosmetic compositions |
| DE10216511A1 (en) * | 2002-04-11 | 2003-10-23 | Beiersdorf Ag | Cosmetic wipes containing starch |
| DE102005038069A1 (en) * | 2005-08-10 | 2007-03-08 | Henkel Kgaa | Oil-in-water emulsions |
| DE102009050430A1 (en) * | 2009-10-22 | 2010-06-17 | Cognis Ip Management Gmbh | Cosmetic preparation, useful as e.g. body oil, baby oil, creams, lotions, sunscreen, liquid and bar soaps, and shower bath foam, comprises a glycerol monoalkyl ether, glycerin dialkylether and cationic surface-active compound |
| DE102017203641A1 (en) * | 2017-03-07 | 2018-09-13 | Beiersdorf Ag | Lipid mixture of octyldodecanol and hydrogenated rapeseed oil |
-
2019
- 2019-08-27 DE DE102019212792.4A patent/DE102019212792A1/en not_active Withdrawn
-
2020
- 2020-08-21 WO PCT/EP2020/073488 patent/WO2021037713A1/en unknown
- 2020-08-21 EP EP20764041.8A patent/EP4021381A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021037713A1 (en) | 2021-03-04 |
| DE102019212792A1 (en) | 2021-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0814753A2 (en) | Cosmetic or dermatological gels based on microemulsions | |
| EP3024433A1 (en) | Transparent sunscreen compositions and use thereof | |
| WO2020043365A1 (en) | Acrylate-free cosmetic emulsion | |
| EP1576949A1 (en) | Combination of the lipids shea butter and cocoa butter for the treatment of ashen skin | |
| DE102004004394A1 (en) | microemulsion | |
| WO2007104740A1 (en) | Silicon free hair cleaning emulsion | |
| WO2018224413A1 (en) | Alkane diols in salt-containing cosmetic preparations | |
| EP4021381A1 (en) | Oil substitute for cosmetic preparations | |
| EP4021380A1 (en) | Particularly natural oil substitute for cosmetic preparations | |
| WO2021037716A1 (en) | Particularly natural oil substitute for cosmetic preparations | |
| EP2008639B1 (en) | New emulsion-form shower preparation | |
| EP3482764B1 (en) | Insect and/or spider repellent comprising black cumin oil | |
| EP3993768A1 (en) | Lipid mixture consisting of liquid oils, hydrogenated vegetable oils, and shea butter | |
| EP4281030A1 (en) | Thermally stable, mineral oil-free w/o emulsion | |
| DE102013219673A1 (en) | Cosmetic use of cosmetic composition comprising extract of Prunella vulgaris, extract of Celosia cristata, hydrolyzed protein, and peptide, which is different from the hydrolyzed protein, for reducing aging signs of the skin | |
| DE102021000268A1 (en) | Cosmetic W/O emulsion free of mineral oil | |
| WO2021249751A1 (en) | Cosmetic product with high degree of emptying of the preparation from the packaging | |
| EP4382088A1 (en) | Emulsions, cosmetic compositions and sunscreens | |
| WO2020048838A1 (en) | Hydrodispersion with panthenol | |
| DE102022204661A1 (en) | Emulsion with liquid crystalline structures | |
| WO2013091977A2 (en) | Use of a combination of taurine and hydrolyzed protein from yeast for increasing epidermal lipid synthesis | |
| DE102019211138A1 (en) | Cosmetic composition | |
| EP3761947A1 (en) | Lipid mixture of stearyl behenate and tristearin | |
| DE202004016689U1 (en) | Cosmetic skin composition contains an arginine (or derivative) and gingko together with ascorbic acid, tocopherol or vitamin or a derivative of these | |
| DE102006008730A1 (en) | Use of cosmetic or dermatological preparation in the form of oil-in-emulsion comprising hydroxymatairesinol for the tightening and/or strengthening of the skin, preferably for cellulite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220328 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20231122 |
|
| RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BEIERSDORF AG |